AzTrials
AzTrials

Primary DysmenorrheaDysM et SOCNCT04083131

Sense of Coherence and Primary Dysmenorrhea in High School Girls in Finistere, France

An observational study of Primary Dysmenorrhea, run by University Hospital, Brest at 6 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study evaluates the relation between sens of coherence and primary dysmenorrhea. Aself-questionnaire is completed by a sample of girls aged between 14 and 19, schooled in Finistère (France). Read more about this study

Who is it for?
Ages 14 to 19 years, women onlyHealthy volunteers can take part
Conditions the study is for
Primary Dysmenorrhea
How many people
255 participants
Where
6 sitesFrance
Study dates
25 Sep 2019to 5 Nov 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 to 19 years
  • Women only
  • Healthy volunteers accepted
  • Child, Adult

Study population: High school girls in Finistère

Who may be able to join

  • student in high schools
  • aged 14 and 19 years
  • with menstrual cycle

Who cannot join

  • Illiteracy
  • student and parents opposition

Trial locations and contacts

6 sites in 1 country.

6 sites in 1 country

France6 sites
  • Lycée de l'Harteloire

    Brest, 29200

  • Lycée Jean-Marie Le Bris

    Douarnenez, 29100

  • Lycée de l'Elorn

    Landerneau, 29800

  • Lycée du Léon

    Landivisiau, 29400

  • Lycée Brizeux

    Quimper, 29000

  • Lycée Roz Glas

    Quimperlé, 29391

Other trials in France

About this study

Official title: Sense of Coherence and Primary Dysmenorrhea in High School Girls in Finistere: Cross-sectional Observational Study

This study evaluates the relation between sens of coherence and primary dysmenorrhea. Aself-questionnaire is completed by a sample of girls aged between 14 and 19, schooled in Finistère (France).

Read the detailed description

Primary dysmenorrhea affects more than 60% of adolescent girls. Menstrual pain increases absenteeism and lowers self-esteem and academic performance. Moreover, dysmenorrheal women suffer more depression and anxiety.

Sense of coherence (SOC) is composed of three items:

  • comprehensibility: what the person understands about his illness
  • manageability: what the person does to cope
  • meaningfulness: what the disease means to the person. A high SOC score is related to good mental and physical health. The aim of this study will be to determine if there is a relationship between primary dysmenorrhea and the sense of coherence.

A self-questionnaire composed of the SOC-13 and a scale evaluating dysmenorrhea will be proposed in the voluntary high schools of Finistère (France) to the girls of the classes chosen at random.

Keywords
Sens of coherence, Primary dysmenorrhea, Salutogenesis, Teenagers

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Presence / absence of dysmenorrhea

    Presence / absence of dysmenorrhea objectified by Visual Analogue Scale (EVA) from 0 to 10 indicating the average pain over the last 3 cycles (if greater than 3 without treatment = primary dysmenorrhea)

    Measured: Inclusion - Day 0

  2. Sense of coherence

    Sense of coherence measured by the self-administered French SOC-13 questionnaire (Likert scale).

    Measured: Inclusion - Day 0

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Sep 2019
  2. Study start25 Sep 2019
  3. Primary completion5 Nov 2019
  4. Study completion5 Nov 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
255 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04083131
Sponsor's protocol ID
DysM et SOC (29BRC19.0112)
Acronym
DysM et SOC
Status last verified
Jan 2020
First submitted
6 Sep 2019
Last updated
7 Jan 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All collected data that underlie results in a publication

Questions about this trial

What is this clinical trial studying?

An observational study of Primary Dysmenorrhea, run by University Hospital, Brest at 6 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Presence / absence of dysmenorrhea (time frame: Inclusion - Day 0). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jan 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in